Carlee Ann Clark MD

MUSC Health is a comprehensive healthcare delivery system that provides a wide range of medical services and specialties, including cancer care, orthopedic services, and rehabilitation programs. With multiple facilities across South Carolina, they emphasize patient-centered care and community involvement through initiatives like Arts in Healing and various volunteer programs. The organization is committed to advancing healthcare through research, education, and evidence-based practices, striving to enhance the quality of care for South Carolinians. MUSC Health also offers virtual care options and extensive resources for patients and families to navigate their healthcare needs effectively. Generated from the website

Claiming South Carolina as home since his youth, it would seem all roads bring Dr. Mathew Wooster back to the charming Lowcountry. Leaving home originally for college at Duke University he returned briefly to complete medical school at MUSC, venturing off again to the University of South Florida where he completed his integrated vascular surgery residency. He now returns to work alongside the very mentors who introduced him to vascular surgery while a medical student at MUSC. Throughout his training, Dr. Wooster has been involved in complex endovascular aortic repair research, as well as participating routinely in the areas of prosthetic graft infections, multi-time redo peripheral bypasses, endovascular limb salvage, and last chance dialysis access creation. In addition to clinical pursuits, Dr. Wooster has been rigorously involved in education serving as a resident member of multiple sub-committees with the Association of Program Directors of Vascular Surgery.Dr. Wooster's clinical interests and training include the breadth of vascular surgical techniques with a special passion for aortic pathology, cerebrovascular disease, and lower extremity limb salvage. Academically, he looks forward to bringing the strong simulation curriculum he was part of in residency to MUSC, improving knowledge about the field among the general public through community outreach, and contributing to the broadening of clinical trial enrollment at the medical university to be able to offer patients access to cutting edge technologic advances.

Dr. Charles Greenberg practices medicine in the area of nonmalignant blood disorders. He provides consultative advice regarding the diagnosis and treatment of bleeding, thrombosis, and disorders of blood cells. Dr. Greenberg conducts translational research regarding new diagnostic tests for management of bleeding and thrombotic disorders. Working in collaborations within the MUSC health care system he assists in management of blood, blood products, and the cost-effective management on nonmalignant blood disorders. Clinical research on the use new approaches to manage bleeding and thrombosis continue as part of national and international groups targeting life-threatening blood disorders. Dr. Greenberg's basic research is in the area of transglutaminase structure and function and he has published in the area of Factor XIII and tissue transglutaminase biology related to hemostasis, thrombosis, wound healing, angiogenesis, and tumor growth.